September 2019 - Page 3 of 3 - CanadianCannabisWire

WednesdaySep 04, 2019 11:03 am

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Rolls Out Online Sales of Discrete Powdered Formulation of CBD-Rich Hemp Oil

Lexaria Bioscience is an innovator in the field of bioavailable lipophilic active compounds, and it is working to make consumption of certain products through oral ingestion a viable alternative to inhalation A particular focus of the company’s technology is to ensure that cannabinoids can enter the blood stream at speeds comparable to smoking and can be used in a discrete manner Cannabis-infused beverage sales are expected to surpass $1.4 billion by 2024, marking a nearly 15-fold increase over 2018 levels Drug bio-delivery technology innovator Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) has launched online commercial delivery of the cannabis industry’s…

WednesdaySep 04, 2019 10:26 am

Nabis Holdings Inc. (CSE: NAB) (OTC: NABIF) (FRA: 71P) Builds Multistate Assets Portfolio as US Cannabis Market Heads for $50 Billion

The U.S. cannabis market is racing along at a 25 percent CAGR Nabis Holdings recently issued a letter to shareholders The company has appointed an independent director Based in Vancouver, Canada, Nabis Holdings Inc. (CSE: NAB) (OTC: NABIF) (FRA: 71P) is targeting positive cash flow and strategic assets in the cannabis space, both in the United States and abroad. Nabis already has investments in Arizona, California, Michigan and Washington and is looking to expand its portfolio to include four to five more states in the next three to four months. Nabis is headed by two industry veterans who exited another firm after receiving one of…